Table 2 Correlation between Mortalin protein expression and the clinicopathological parameters of breast cancer
Variables | No. of cases | Mortalin strongly positive cases (%) | χ 2 | P value |
|---|---|---|---|---|
Age | 0.044 | 0.834 | ||
≥50 | 82 | 53 (64.6 %) | ||
<50 | 73 | 46 (63.0 %) | ||
Menopausal status | 0.839 | 0.361 | ||
premenopausal | 74 | 50 (67.6 %) | ||
Postmenopausal | 81 | 49 (60.5 %) | ||
Histological grade | 7.971 | 0.019** | ||
Grade-1 | 62 | 32 (51.6 %) | ||
Grade-2 | 48 | 32 (66.7 %) | ||
Grade-3 | 45 | 35 (77.8 %) | ||
Clinical stage | 6.981 | 0.008** | ||
0-II | 92 | 51 (55.4 %) | ||
III-IV | 63 | 48 (76.2 %) | ||
LN metastasis | 6.364 | 0.012** | ||
Absent | 76 | 41 (53.9 %) | ||
Presence | 79 | 58 (73.4 %) | ||
ER | 1.082 | 0.300 | ||
Positive | 94 | 57 (60.6 %) | ||
Negative | 61 | 42 (68.8 %) | ||
PR | 0.926 | 0.338 | ||
Positive | 89 | 54 (60.7 %) | ||
Negative | 66 | 45 (68.2 %) | ||
Her2 status | 1.609 | 0.206 | ||
Positive | 96 | 65 (67.7 %) | ||
Negative | 59 | 34 (57.6 %) |